GRIN2B and Alzheimer disease: To understand the molecular basis of increased extrasynaptic GluN2B receptor localization in AD, we assessed the expression of casein kinase II alpha (CK2α), the enzyme known to phosphorylate GluN2B at Ser1480, thereby promoting its extrasynaptic localization, and the corresponding levels of pGluN2B.